• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心房利钠肽基因多态性与肥厚型心肌病无关。

Atrial natriuretic peptide gene polymorphism is not associated with hypertrophic cardiomyopathy.

机构信息

Department of Cardiology, Chinese People's Liberation Army General Hospital, and Peking Union Medical College, Beijing 100853, China.

出版信息

Chin Med J (Engl). 2010 Jan 20;123(2):188-92.

PMID:20137368
Abstract

BACKGROUND

Hypertrophic cardiomyopathy (HCM) is a primary autosomal dominant inheritant myocardial disease with heterogeneity in clinical manifestations, natural history and prognosis. Even carrying an identical gene mutation among family members, a variety of clinical phenotypes have been found in patients with HCM. Modifier genes may contribute to the diversity. The plasma levels of atrial natriuretic peptides (ANP) were found previously to be elevated in HCM. Our studies suggested that ANP gene promoter polymorphism is associated with left ventricular hypertrophy in hypertension. The present study aimed to determine whether the two SNPs in the ANP gene are associated with HCM.

METHODS

We determined the relationships between the ANP gene polymorphism and HCM in 262 HCM patients and 614 age- and sex-matched healthy individuals. All of the subjects were genotyped for -A2843G and A188G polymorphisms.

RESULTS

The genotype frequency in the -A2843G and A188G polymorphisms of the ANP gene was not significantly different between the HCM patients and controls. The -A2843G and A188G polymorphisms were also not associated with clinical phenotype in cardiomyopathy patients.

CONCLUSIONS

The polymorphisms of the ANP gene are not associated with increasing risk of HCM or clinical phenotypes. The variations of the ANP gene may not serve as a genetic modifier for the development of HCM.

摘要

背景

肥厚型心肌病(HCM)是一种主要的常染色体显性遗传心肌疾病,临床表现、自然病史和预后存在异质性。即使家族成员携带相同的基因突变,也会在 HCM 患者中发现各种临床表型。修饰基因可能导致这种多样性。先前发现,HCM 患者的血浆心房利钠肽(ANP)水平升高。我们的研究表明,ANP 基因启动子多态性与高血压中的左心室肥厚有关。本研究旨在确定 ANP 基因中的两个 SNP 是否与 HCM 相关。

方法

我们在 262 名 HCM 患者和 614 名年龄和性别匹配的健康个体中确定了 ANP 基因多态性与 HCM 之间的关系。所有受试者均对 -A2843G 和 A188G 多态性进行基因分型。

结果

ANP 基因的 -A2843G 和 A188G 多态性的基因型频率在 HCM 患者和对照组之间没有显著差异。-A2843G 和 A188G 多态性也与心肌病患者的临床表型无关。

结论

ANP 基因的多态性与增加 HCM 或临床表型的风险无关。ANP 基因的变异可能不作为 HCM 发生的遗传修饰因子。

相似文献

1
Atrial natriuretic peptide gene polymorphism is not associated with hypertrophic cardiomyopathy.心房利钠肽基因多态性与肥厚型心肌病无关。
Chin Med J (Engl). 2010 Jan 20;123(2):188-92.
2
Polymorphisms of angiotensin-converting enzyme 2 gene associated with magnitude of left ventricular hypertrophy in male patients with hypertrophic cardiomyopathy.血管紧张素转换酶2基因多态性与男性肥厚型心肌病患者左心室肥厚程度相关。
Chin Med J (Engl). 2008 Jan 5;121(1):27-31.
3
Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy.对389例无亲缘关系的肥厚型心肌病患者的β-肌球蛋白重链基因进行综合分析。
J Am Coll Cardiol. 2004 Aug 4;44(3):602-10. doi: 10.1016/j.jacc.2004.04.039.
4
Gene-specific modifying effects of pro-LVH polymorphisms involving the renin-angiotensin-aldosterone system among 389 unrelated patients with hypertrophic cardiomyopathy.389例非亲缘关系肥厚型心肌病患者中肾素-血管紧张素-醛固酮系统相关促左心室肥厚多态性的基因特异性修饰作用
Eur Heart J. 2005 Nov;26(22):2457-62. doi: 10.1093/eurheartj/ehi438. Epub 2005 Aug 8.
5
Genetic analysis of the atrial natriuretic peptide gene in essential hypertension.原发性高血压中心房利钠肽基因的遗传分析。
Clin Sci (Lond). 2000 Mar;98(3):251-8.
6
Diastolic dysfunction without left ventricular hypertrophy is an early finding in children with hypertrophic cardiomyopathy-causing mutations in the beta-myosin heavy chain, alpha-tropomyosin, and myosin-binding protein C genes.在因β-肌球蛋白重链、α-原肌球蛋白和肌球蛋白结合蛋白C基因发生肥厚型心肌病相关突变的儿童中,舒张功能障碍且无左心室肥厚是早期发现。
Am Heart J. 2006 Mar;151(3):725.e1-725.e9. doi: 10.1016/j.ahj.2005.12.005.
7
Atrial natriuretic peptide gene promoter polymorphism is associated with left ventricular hypertrophy in hypertension.心房利钠肽基因启动子多态性与高血压患者左心室肥厚相关。
Clin Sci (Lond). 2008 Jan;114(2):131-7. doi: 10.1042/CS20070109.
8
Hypertrophic cardiomyopathy in a Portuguese population: mutations in the myosin-binding protein C gene.葡萄牙人群中的肥厚型心肌病:肌球蛋白结合蛋白C基因的突变
Rev Port Cardiol. 2005 Dec;24(12):1463-76.
9
Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype.具有限制性表型的肥厚型心肌病的患病率、临床意义及遗传基础。
J Am Coll Cardiol. 2007 Jun 26;49(25):2419-26. doi: 10.1016/j.jacc.2007.02.061. Epub 2007 Jun 11.
10
Resistin gene promoter region polymorphism and the risk of hypertrophic cardiomyopathy in patients.抵抗素基因启动子区多态性与肥厚型心肌病患者的风险。
Transl Res. 2010 Mar;155(3):142-7. doi: 10.1016/j.trsl.2009.10.002. Epub 2009 Nov 4.

引用本文的文献

1
The influence of Angiotensin converting enzyme and angiotensinogen gene polymorphisms on hypertrophic cardiomyopathy.血管紧张素转换酶和血管紧张素原基因多态性对肥厚型心肌病的影响。
PLoS One. 2013 Oct 25;8(10):e77030. doi: 10.1371/journal.pone.0077030. eCollection 2013.